RT @MdJpn: 多様性に対応すべく備わった自然免疫を破壊し、一律の「免疫変異体」にしようとしてる。変異する度に接種することになる。 多様性を認めよう!個性を大切に!オンリーワンになろう!が、2015年にSDGSが採択されると、同じ価値観!誰一人置いてかない!に一転。…
RT @MdJpn: 多様性に対応すべく備わった自然免疫を破壊し、一律の「免疫変異体」にしようとしてる。変異する度に接種することになる。 多様性を認めよう!個性を大切に!オンリーワンになろう!が、2015年にSDGSが採択されると、同じ価値観!誰一人置いてかない!に一転。…
RT @RealCheckMarker: SARS ability of genetic recombination to produce variants that will evade whatever new challenge of immunity is why "h…
👇
RT @SourceControl21: @GrGuenter @Silvieann2 Ja, interessant, solch einen Artikel in den deutschen Medien zu finden Schade dass Prävention…
@GrGuenter @Silvieann2 Ja, interessant, solch einen Artikel in den deutschen Medien zu finden Schade dass Prävention durch saubere Luft und Quellenkontrolle unerwähnt bleiben. #CovidIsNotOver #CovidIsAirborne #SARSCoV2 👀👇 💣 https://t.co/qKfGmnizX2
@dirvarda All of the articles I’ve linked are well over a year old but this one is too damning like Yoo the world is cooked 😭😭😭 https://t.co/uF8bWeCIaO
RT @RealCheckMarker: SARS ability of genetic recombination to produce variants that will evade whatever new challenge of immunity is why "h…
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/rMYvC7G7cU
@PGrivasMDPhD @DrJNaidoo @HaanenJohn @myESMO Dear Petros, Are you aware those mass gathering events especially from health experts contribute to #SARSCoV2 transmissions into #healthcare establishments worldwide? https://t.co/SxfWjKYdzE
@ryanbeed @Bork10Bork @PierreKory @drpaulmarik1 @P_McCulloughMD @richardursomd @drcole12 @lawrie_dr @MdBreathe @SenRonJohnson Just like what they said about the BIVALENT boost https://t.co/QzW9WLHyz4 https://t.co/odDpq4oMhj
@thuisblijvend @mkeulemans 2. De nieuwste subvarianten zijn uitstekend in staat om antilichamen te neutraliseren en zo de immuunreactie uit te schakelen: https://t.co/CMgCcz6WWB
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/N3ccIbvHJS 2022
Todas las vacunas son efectivas para reducir la prob. de enfermedad grave. Empero, las vacunas actualizadas son una herramienta importante para contender contra el escape inmune de las nuevas variantes. Y aún así son insuficientes. https://t.co/SfNNklghni
@OmicronData I mean we've been here before, with a journal that's supposed somewhat responsible ... https://t.co/XvblmnTAcQ
@ShiraDoronMD @EWidera Even experts have done it: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/XvblmnTAcQ
RT @RealCheckMarker: SARS ability of genetic recombination to produce variants that will evade whatever new challenge of immunity is why "h…
@EnigmaMachine8 @FactsAreGood @tenebra99 2/ Note that omicron variant has high re-infection among unvax prior infected, just as w/vaccine due to the substantial antigen delta that I explained. + "ALL cause" mortality is just that; not "Vax/C19 mortality"
RT @dialucrii31: @Justanewsletter @KevCTNC @D_Bone And this is why you don't base a vaccine around that part of the virus which is most pro…
@Pegasus311 えっと、この動画 https://t.co/n8uqrKAO9k で紹介されているこの論文 「Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants」 https://t.co/AsojVBCBHe のことですかね? ここでは、XBB.1 が Omicron サブバリアントの中で最も抗原的に異なる。…
@GobiernoMX Esto responde a que las variantes omicrónicas más derivadas (como las de los clados XBB y BQ) son incluso más distantes del SARS-CoV-2 original como éste lo es del SARS-CoV-1 que causó la pandemia de SARS del 2002. https://t.co/6Nv6Af1hdL
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/McqIyXnf7h
RT @ma_pion: 🎙こんなものを打たされている日本人 https://t.co/HYk3Z94c1I Cell論文より https://t.co/xzE3f6cNmx
コロナ2価ワクチンはXBB型に効果なし。武漢型やBA2型ワクチンを何度も打った人はXBB単価ワクチンの効果なし。 Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants: Cell https://t.co/mjIviB4uCp https://t.co/iAb85nKaAs
🎙こんなものを打たされている日本人 https://t.co/HYk3Z94c1I Cell論文より https://t.co/xzE3f6cNmx
鹿先生 ●永遠に無効なコロナワクチン https://t.co/2ebPCfbQzY https://t.co/mNkLwTAEzb https://t.co/9wugj70X3B%
https://t.co/dakr4PaWO6 増加する SARS-CoV-2 BQ および XBB サブバリアントの驚くべき抗体回避特性
「百害あって一利なし」の💉をこれから、どうするか、結論でましたね IF68.81のCellに決定的な論文が、掲載されました https://t.co/BNjZqfl4mG
@NimesTadpole @LeeAdamWilshier @SueSueCurious @nilikm Repeat infections because of repeated exposure to the virus, which also continues to evolve. https://t.co/WfWIhDkyXP https://t.co/1yV34lKD14
@TheEliKlein @hholdenthorp @sciencecohen Of course, although the neutralizing subset of the anti-S antibodies are relevant for infection protection, they can fall to low levels without much decline in severe disease protection (so despite titles like https
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/ph9OCNEzvR
The alarming antibody evasion properties of two SARS-CoV-2 BQ and XBB subvariants have been uncovered. https://t.co/06Qruq1AY7
@ryanbeed @MayassiSabia @zwergie1 @sleightHanded @ptcjoneses @Opportunitweet @snorman1776 @jeffreyatucker @19joho From another perspective: "Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants" https://t.co/xts4Y51CrZ https://t
Dez 2022 "Together, our findings indicate that BQ and XBB subvariants present serious threats to current #COVID19-19 vaccines, render inactive all authorized antibodies, & may have gained dominance in the population because of their advantage in evadin
@gregggonsalves @JAMANetworkOpen @JAMANetwork Full article links…
RT @jhillmd: “BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and m…
“BQ and XBB subvariants present serious threats to current COVID-19 vaccines, render inactive all authorized antibodies, and may have gained dominance in the population because of their advantage in evading antibodies.” https://t.co/aSi509Fmjb
@LangstrumpfPipo @tinadeplazes @danieljositsch @sciencezoe 2/ Bild 1: https://t.co/3nmvwksAEx Bild 2: https://t.co/cAPEj80Gw6 Bild 3+4: Die Cleveland Clinic Studie die zeigt, mehr Impfungen = noch mehr Ansteckungen, IST JETZT PEER-REVIEWED! https://t.co/
RT @RealCheckMarker: SARS ability of genetic recombination to produce variants that will evade whatever new challenge of immunity is why "h…
RT @RealCheckMarker: SARS ability of genetic recombination to produce variants that will evade whatever new challenge of immunity is why "h…
RT @LucasLealMontes: Enlace 62: https://t.co/qDAdpHR3KJ https://t.co/qSb3zgDVUc
RT @LucasLealMontes: Enlace 62: https://t.co/qDAdpHR3KJ https://t.co/qSb3zgDVUc
Enlace 62: https://t.co/qDAdpHR3KJ https://t.co/qSb3zgDVUc
@loquat_priest @DrMagicianEARL sotrovimabがIC50の観点から比較的マシ?に見える話はちょいちょいありますよね https://t.co/Nct3i04VGr
@DavidJoffe64 @1goodtern @profmiketoole Study 1: https://t.co/KaF3BIw6vN Study 2: https://t.co/mkHjgxJRkR
@cclareMDMPH Just curious, what do you think gets boosted by these shots, professor? Because all the latest research shows its definitely not functional antibodies... https://t.co/OQofEGWVPI https://t.co/xQMEFbHD1c https://t.co/lGjm7IcopB https://t.co/nrrn
@1goodtern Study for chart 1 above https://t.co/KaF3BIw6vN Study for charts 2 & 3 https://t.co/mkHjgxJRkR
Rock bottom neutralization levels for XBB.1 variants mean that no on can reasonably expect infection protection While those with prior infections have slightly more neutralization, the levels are still abysmal 2/
Haiyaaaaa
ที่น่ากลัวคือ Variant BQ, XBB มันหลบภูมิสร้างจาก mRNA ทั้ง ตัวหลัก และ Bivalent ที่มีใช้ในตลาดขณะนี้ https://t.co/FHMbpcqM6y
@alexandrosM Study 1: https://t.co/KaF3BIwEll Study 2: https://t.co/mkHjgxKpap
@dragonfishy Thanks, Doc! There's an abundance of studies that show that immune imprinting is driving large scale immune escape. Govs won't act. We have to make the unjabbed aware, so they can protect jabbed loved ones! https://t.co/EPBVb5pNA0 https://t.co
RT @_LeMoog_: Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants https://t.co/wFXCK7bJA2
@TRyanGregory Boyton and Altmann cite Wang et al (2023) for that claim: "XBB and XBB.1 are now antigenically more distant than SARS-CoV or some sarbecoviruses in animals (Figure S3)." But antigenic distance is but one VERY specific difference between vir
@rt7683 @jason_willz1 @Borgechr @VigilantFox 1-19-2023 “BQ &XBB subvariants of SARS-CoV-2 demonstrate dramatically increased ability to evade neutralizing antibodies, even those from people who received the bivalent mRNA booster or who are immunized an
@rt7683 @jason_willz1 @Borgechr @VigilantFox Enjoy your mRNA gene therapy 🧬 BIVALENT booster..tested on 8 mice It’s crap 💩 https://t.co/QzW9WLH0Jw https://t.co/jxifOlH1TZ
@GosiaGasperoPhD Yes, of course - the images are from 2 separate studies Image on left is from: https://t.co/KaF3BIwEll Two images on right are from: https://t.co/mkHjgxKpap
Easy!!
RT @flowermusickids: @DrStephanieCoo1 @ChrisReid @amandalhu Here’s some updated info. The current set of vaccines do NOT prevent illness or…
@DrStephanieCoo1 Fact check: the dominant strains of SARS-CoV-2 virus evade antibodies to infection only, vaccination only, & “hybrid immunity”. https://t.co/y4HceVEhyo There is zero evidence a “mild” course of C19 is incapable of disabling an individu
@DrStephanieCoo1 @ChrisReid @amandalhu Here’s some updated info. The current set of vaccines do NOT prevent illness or transmission of SARS2: https://t.co/y4HceVEhyo Omicron results in ⬆️ shedding. I wear a P100 at all times in public. We need respirator
@ewyler Maybe this helps? https://t.co/vDLkx2qtKq
@BarryESharp @tigresseleanor @Sharky_vs_Evil The variants still haven’t evaded the antibodies https://t.co/OxWGVi0pa6
@BarryESharp @Sharky_vs_Evil @tigresseleanor It was nowhere near as immune evasive as Omicron and even with Omicron the vaccines work. Too hard for your feeble mind to comprehend https://t.co/OxWGVi0pa6
RT @tak53381102: オミクロン用二価ワクチンを接種した人やBA.5に感染した人の血清抗体は新規変異株に対して中和活性を持つかどうか(Cell. 2022 Dec 14). 既報同様、二価ワクチン接種後も、BA.5感染しても、抗体はXBBを中和しない。できるだけ日本…
@CovidDataReport Study 1 https://t.co/KaF3BIw6vN Study 2 https://t.co/mkHjgxJRkR
* • Serum neutralization was markedly reduced, including with the bivalent booster • All clinical monoclonal antibodies were rendered inactive against these variants • The ACE2 affinity of these variants were similar to their parental strains * https:
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - ScienceDirect * Highlights • BQ.1, BQ.1.1, XBB, and XBB.1 are the most resistant SARS-CoV-2 variants to date * https://t.co/bBk4OYzpSZ
Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants - ScienceDirect https://t.co/bBk4OYzpSZ
RT @LisaForKansas: @1goodtern Unfortunately with currently circulating variants (XBB.1), barely any neutralization is seen⬇️↘️ It’s becomi…
RT @LisaForKansas: @1goodtern Unfortunately with currently circulating variants (XBB.1), barely any neutralization is seen⬇️↘️ It’s becomi…
RT @LisaForKansas: @1goodtern Unfortunately with currently circulating variants (XBB.1), barely any neutralization is seen⬇️↘️ It’s becomi…
RT @LisaForKansas: @1goodtern Unfortunately with currently circulating variants (XBB.1), barely any neutralization is seen⬇️↘️ It’s becomi…
RT @LisaForKansas: @1goodtern Unfortunately with currently circulating variants (XBB.1), barely any neutralization is seen⬇️↘️ It’s becomi…